Category REGENERATIVE MEDICINE

Novartis’ Phase III studies of ofatumumab achieve primary goals in relapsing multiple sclerosis

Novartis has reported positive findings from the Phase III ASCLEPIOS I and II clinical trials of ofatumumab (OMB157), which met their primary endpoints in relapsing forms of multiple sclerosis (RMS) patients. Ofatumumab is an anti-CD20 monoclonal antibody (mAb) designed to cause B-cell lysis and depletion. It has been formulated for once-monthly, subcutaneous self-administration. The identical

Read More


University of Pennsylvania Announces Completion of Exclusive R&D Alliance With Novartis and Development of New Focused Relationship

Penn to Broaden Pathways for Development of New CAR T Cell Therapies Following a landmark, first-of-its-kind collaboration that spawned the global CAR T cell therapy industry, the University of Pennsylvania and Novartis have concluded their seven-year research and development alliance, which resulted in the world’s first approved gene therapy for cancer. They will continue to

Read More


Gene therapy may help functional recovery after stroke

A new gene therapy turns glial cells — abundant support cells in the brain — into neurons, repairing damage that results from stroke and significantly improving motor function in mice. A paper describing the new therapy, which uses the NeuroD1 gene, appears online in the journal Molecular Therapy. Once further developed, this NeuroD1-based gene therapy potentially

Read More


#ECTRIMS2019 — Promises and Warnings About Stem Cell Therapy in Multiple Sclerosis

Stem cell therapy, or stem cell transplant, is an emerging yet controversial treatment approach for multiple sclerosis (MS). While some data uphold it as one of the most efficacious MS treatments, to date there have been no controlled studies comparing it to conventional medicines and providing more robust evidence regarding its safety and clinical benefit. Under the topic

Read More


CAR T-Cell Therapy May Be Harnessed to Treat Heart Disease

Penn study finds immunotherapy reduces cardiac fibrosis and restores heart function in mice after cardiac injury CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients’ own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease. In a first-of-its-kind study, published today in Nature, researchers

Read More


Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56

The inhibitory receptors PD-1, Tim-3, and Lag-3 are highly expressed on tumor-infiltrating lymphocytes and compromise their antitumor activity. For efficient cancer immunotherapy, it is important to prevent chimeric antigen receptor T (CAR-T)-cell exhaustion. Here we downregulate these three checkpoint receptors simultaneously on CAR-T cells and that show the resulting PTL-CAR-T cells undergo epigenetic modifications and better control

Read More


Director of Besta Neurologic Institute of Milan:”There is no experimental stem cell-based treatment that has a positive effect for patients in a state of minimal consciousness like Michael Schumacher.”

Source Il Messaggero Matilde Leonardi, director of the Coma Research Center of the Besta Neurological Institute in Milan and a member of the Italian Society of Neurology, wants to be immediately clear. “The news about the former pilot is only fueling false hopes and deluding patients’ families.” Why is she so convinced that this therapy

Read More


The potential use of mesenchymal stem cells for the treatment of multiple sclerosis

Source https://www.sciencedirect.com/science/article/abs/pii/S002432051930757X?via%3Dihub&elqTrackId=b210a4797cc6484b94cf773fe330c747&elq=012dbc43f12c4386bdd3fa0ea93bb255&elqaid=26027&elqat=1&elqCampaignId=10598 Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system (CNS). In attempt to identify an appropriate treatment for improving the neurological symptoms and remyelination process, autologous and allogenic transplantation of mesenchymal stem cells (MSCs) have been introduced as an effective therapeutic strategy in MS. MSCs are a heterogeneous

Read More